A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients

Background Hyperuricemia occurs frequently in patients with continuous ambulatory peritoneal dialysis (CAPD). This study aimed to evaluate the impact of serum uric acid (UA) over time on residual renal function (RRF) loss in a cohort of patients with CAPD. Methods A total of 201 patients who started...

Full description

Bibliographic Details
Main Authors: Chiehlun Yang, Xinxin Ma, Wenbo Zhao, Yanru Chen, Hongchun Lin, Dan Luo, Jun Zhang, Tanqi Lou, Yu Peng, Hui Peng
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
Online Access:http://dx.doi.org/10.1080/0886022X.2020.1761387
_version_ 1818914850694234112
author Chiehlun Yang
Xinxin Ma
Wenbo Zhao
Yanru Chen
Hongchun Lin
Dan Luo
Jun Zhang
Tanqi Lou
Yu Peng
Hui Peng
author_facet Chiehlun Yang
Xinxin Ma
Wenbo Zhao
Yanru Chen
Hongchun Lin
Dan Luo
Jun Zhang
Tanqi Lou
Yu Peng
Hui Peng
author_sort Chiehlun Yang
collection DOAJ
description Background Hyperuricemia occurs frequently in patients with continuous ambulatory peritoneal dialysis (CAPD). This study aimed to evaluate the impact of serum uric acid (UA) over time on residual renal function (RRF) loss in a cohort of patients with CAPD. Methods A total of 201 patients who started CAPD therapy between January 1, 2008 and April 30, 2016 were included in this single-center, retrospective cohort study. All patients were followed up until December 31, 2016. The median follow-up time was 23.43 ± 16.60 months. RRF loss was represented as the time to anuria. Results Eighty-six patients developed anuria within 5 years. Multivariate Cox regression analysis showed that time-averaged serum UA and peritonitis were independent risk factors for RRF loss, while weekly Kt/V urea was a protective factor. Cox proportional hazard regression models showed that both patients with time-averaged uric acid (TA-UA) < 6.77 mg/dL [hazard ratio (HR) = 1.165, 95% confidence interval (CI) 1.054–1.387; p < 0.05] and those with TA-UA≥ 7.64 mg/dL (HR = 1.184, 95% CI 1.045–2.114; p < 0.05) had a higher risk of RRF than those with TA-UA in the range of 6.77–7.64 mg/dL. Penalized spline smoothing also showed a U-shaped relationship between continuous UA and RRF loss. Conclusion The present study demonstrated that both high and low serum UA over time were associated with RRF loss in patients with CAPD.
first_indexed 2024-12-19T23:52:56Z
format Article
id doaj.art-196498917d6244acb60dd9109ec0013c
institution Directory Open Access Journal
issn 0886-022X
1525-6049
language English
last_indexed 2024-12-19T23:52:56Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj.art-196498917d6244acb60dd9109ec0013c2022-12-21T20:01:04ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492020-01-0142144745410.1080/0886022X.2020.17613871761387A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patientsChiehlun Yang0Xinxin Ma1Wenbo Zhao2Yanru Chen3Hongchun Lin4Dan Luo5Jun Zhang6Tanqi Lou7Yu Peng8Hui Peng9Nephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityNephrology Division, Department of Medicine, Guangdong Province Traditional Chinese Medical HospitalNephrology Division, Department of Medicine, The Third Affiliated Hospital of Sun Yat-Sen UniversityBackground Hyperuricemia occurs frequently in patients with continuous ambulatory peritoneal dialysis (CAPD). This study aimed to evaluate the impact of serum uric acid (UA) over time on residual renal function (RRF) loss in a cohort of patients with CAPD. Methods A total of 201 patients who started CAPD therapy between January 1, 2008 and April 30, 2016 were included in this single-center, retrospective cohort study. All patients were followed up until December 31, 2016. The median follow-up time was 23.43 ± 16.60 months. RRF loss was represented as the time to anuria. Results Eighty-six patients developed anuria within 5 years. Multivariate Cox regression analysis showed that time-averaged serum UA and peritonitis were independent risk factors for RRF loss, while weekly Kt/V urea was a protective factor. Cox proportional hazard regression models showed that both patients with time-averaged uric acid (TA-UA) < 6.77 mg/dL [hazard ratio (HR) = 1.165, 95% confidence interval (CI) 1.054–1.387; p < 0.05] and those with TA-UA≥ 7.64 mg/dL (HR = 1.184, 95% CI 1.045–2.114; p < 0.05) had a higher risk of RRF than those with TA-UA in the range of 6.77–7.64 mg/dL. Penalized spline smoothing also showed a U-shaped relationship between continuous UA and RRF loss. Conclusion The present study demonstrated that both high and low serum UA over time were associated with RRF loss in patients with CAPD.http://dx.doi.org/10.1080/0886022X.2020.1761387peritoneal dialysisuric acidresidual renal functionend-stage renal disease
spellingShingle Chiehlun Yang
Xinxin Ma
Wenbo Zhao
Yanru Chen
Hongchun Lin
Dan Luo
Jun Zhang
Tanqi Lou
Yu Peng
Hui Peng
A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
Renal Failure
peritoneal dialysis
uric acid
residual renal function
end-stage renal disease
title A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
title_full A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
title_fullStr A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
title_full_unstemmed A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
title_short A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
title_sort longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients
topic peritoneal dialysis
uric acid
residual renal function
end-stage renal disease
url http://dx.doi.org/10.1080/0886022X.2020.1761387
work_keys_str_mv AT chiehlunyang alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT xinxinma alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT wenbozhao alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT yanruchen alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT hongchunlin alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT danluo alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT junzhang alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT tanqilou alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT yupeng alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT huipeng alongitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT chiehlunyang longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT xinxinma longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT wenbozhao longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT yanruchen longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT hongchunlin longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT danluo longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT junzhang longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT tanqilou longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT yupeng longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients
AT huipeng longitudinalanalysisoftherelationshipbetweenserumuricacidandresidualrenalfunctionlossinperitonealdialysispatients